T46.0X2
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by cardiac-stimulant glycosides and similar drugs involves the accidental or intentional intake of substances that affect the heart's functioning. These medications, often used to treat heart conditions like heart failure or arrhythmias, can be dangerous if misused or taken in excessive amounts. When such poisoning is intentional, it is usually linked to self-harm behaviors. Recognizing the risks and understanding the potential effects of these substances are important for timely medical intervention.
Causes & Symptoms
Clinical Causes: Intentional overdose or self-harm attempts involving cardiac-stimulant glycosides, such as digoxin or digitoxin. Accidental ingestion of medications, especially in children or individuals with cognitive impairments. Misuse of heart medications by individuals attempting to self-medicate without proper guidance. Lack of awareness about the potency of these drugs leading to overconsumption.
Key Symptoms: Nausea and vomiting Blurred or yellow-tinted vision Confusion or dizziness Irregular heartbeat or palpitations Weakness or fatigue Low blood pressure Abdominal pain Seizures in severe cases Dizziness or fainting spells Shortness of breath
Diagnostic & Treatment
Diagnosis Path: Diagnosing poisoning by cardiac-stimulant glycosides typically involves a combination of medical history, physical examination, and laboratory tests. Blood tests can measure the level of glycosides in the bloodstream to confirm overdose. An ECG (electrocardiogram) may also be performed to detect abnormal heart rhythms characteristic of toxicity. Additional assessments may include kidney and liver function tests to evaluate organ involvement and overall health status.
Treatment Protocols: Treatment for poisoning caused by cardiac-stimulant glycosides includes several approaches, often provided in a hospital setting: - **Monitoring:** Continuous heart monitoring to observe any abnormal rhythms. - **Activated charcoal:** To limit the absorption of the drug from the gastrointestinal tract if ingestion was recent. - **Specific antidote:** Such as digoxin-specific antibody fragments (digoxin immune Fab) for severe cases of overdose. - **Electrolyte correction:** Managing imbalances, particularly potassium and magnesium levels, to reduce cardiac risks. - **Supportive care:** Including intravenous fluids and medications to stabilize blood pressure and heart rate. - **Psychological support:** Addressing the underlying reasons for the intentional self-harm, which may involve mental health professionals. Early recognition and prompt medical intervention are essential for reducing the risk of serious complications or death from glycoside poisoning.
Clinical Advice & FAQs
Billing Guidance
Is T46.0X2 a billable ICD-10 code?
Yes, T46.0X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.0X2?
Clinical documentation must specify the nature of Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference